These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18717631)

  • 21. Naringenin protects against 6-OHDA-induced neurotoxicity via activation of the Nrf2/ARE signaling pathway.
    Lou H; Jing X; Wei X; Shi H; Ren D; Zhang X
    Neuropharmacology; 2014 Apr; 79():380-8. PubMed ID: 24333330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease.
    Beal MF
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S189-94. PubMed ID: 20082988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxisome Proliferator Activated Receptor Gamma Coactivator 1 Alpha: An Emerging Target for Neuroprotection in Parkinson's Disease.
    Das NR; Sharma SS
    CNS Neurol Disord Drug Targets; 2015; 14(8):1024-30. PubMed ID: 25808897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
    Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A
    Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic or pharmacological activation of the Drosophila PGC-1α ortholog spargel rescues the disease phenotypes of genetic models of Parkinson's disease.
    Ng CH; Basil AH; Hang L; Tan R; Goh KL; O'Neill S; Zhang X; Yu F; Lim KL
    Neurobiol Aging; 2017 Jul; 55():33-37. PubMed ID: 28407521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxynitrite in the pathogenesis of Parkinson's disease and the neuroprotective role of metallothioneins.
    Ebadi M; Sharma SK; Ghafourifar P; Brown-Borg H; El Refaey H
    Methods Enzymol; 2005; 396():276-98. PubMed ID: 16291239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medicinal Plants as Protective Strategies Against Parkinson's Disease.
    Mazo NA; Echeverria V; Cabezas R; Avila-Rodriguez M; Tarasov VV; Yarla NS; Aliev G; Barreto GE
    Curr Pharm Des; 2017; 23(28):4180-4188. PubMed ID: 28302024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effect of bromocriptine against BH4-induced Cath.a cell death involving up-regulation of antioxidant enzymes.
    Lim JH; Kim SS; Boo DH; No H; Kang BY; Kim EM; Hwang O; Choi HJ
    Neurosci Lett; 2009 Feb; 451(3):185-9. PubMed ID: 19146917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lithium and valproate acid protect NSC34 cells from H2O2-induced oxidative stress and upregulate expressions of SIRT3 and CARM1.
    Wang J; Feng H; Zhang J; Jiang H
    Neuro Endocrinol Lett; 2013; 34(7):648-54. PubMed ID: 24464007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease.
    Zbarsky V; Datla KP; Parkar S; Rai DK; Aruoma OI; Dexter DT
    Free Radic Res; 2005 Oct; 39(10):1119-25. PubMed ID: 16298737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective role of SIRT5 against motor deficit and dopaminergic degeneration in MPTP-induced mice model of Parkinson's disease.
    Liu L; Peritore C; Ginsberg J; Shih J; Arun S; Donmez G
    Behav Brain Res; 2015 Mar; 281():215-21. PubMed ID: 25541039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ceftriaxone mediated rescue of nigral oxidative damage and motor deficits in MPTP model of Parkinson's disease in rats.
    Bisht R; Kaur B; Gupta H; Prakash A
    Neurotoxicology; 2014 Sep; 44():71-9. PubMed ID: 25053526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isotopic reinforcement of essential polyunsaturated fatty acids diminishes nigrostriatal degeneration in a mouse model of Parkinson's disease.
    Shchepinov MS; Chou VP; Pollock E; Langston JW; Cantor CR; Molinari RJ; Manning-Boğ AB
    Toxicol Lett; 2011 Nov; 207(2):97-103. PubMed ID: 21906664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondria: prospective targets for neuroprotection in Parkinson's disease.
    Yadav A; Agarwal S; Tiwari SK; Chaturvedi RK
    Curr Pharm Des; 2014; 20(35):5558-73. PubMed ID: 24606805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phytic acid attenuates inflammatory responses and the levels of NF-κB and p-ERK in MPTP-induced Parkinson's disease model of mice.
    Lv Y; Zhang Z; Hou L; Zhang L; Zhang J; Wang Y; Liu C; Xu P; Liu L; Gai X; Lu T
    Neurosci Lett; 2015 Jun; 597():132-6. PubMed ID: 25929185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective effects of Chunghyuldan against ROS-mediated neuronal cell death in models of Parkinson's disease.
    Kim HG; Ju MS; Kim DH; Hong J; Cho SH; Cho KH; Park W; Lee EH; Kim SY; Oh MS
    Basic Clin Pharmacol Toxicol; 2010 Dec; 107(6):958-64. PubMed ID: 20629656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curcumin protects against A53T alpha-synuclein-induced toxicity in a PC12 inducible cell model for Parkinsonism.
    Liu Z; Yu Y; Li X; Ross CA; Smith WW
    Pharmacol Res; 2011 May; 63(5):439-44. PubMed ID: 21237271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repression of rRNA transcription by PARIS contributes to Parkinson's disease.
    Kang H; Shin JH
    Neurobiol Dis; 2015 Jan; 73():220-8. PubMed ID: 25315684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abrogating Oxidative Stress as a Therapeutic Strategy Against Parkinson's Disease: A Mini Review of the Recent Advances on Natural Therapeutic Antioxidant and Neuroprotective Agents.
    Theofanous T; Kourti M
    Med Chem; 2022; 18(7):772-783. PubMed ID: 35249501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of the aging risk factor for Parkinson's disease.
    Phillipson OT
    Neurobiol Aging; 2014 Apr; 35(4):847-57. PubMed ID: 24246717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.